Stock | Role | Class | Num Shares | Value | Price $ | Report Date | Ownership |
---|---|---|---|---|---|---|---|
Sana Biotechnology, Inc. | Director | Stock Option (Right to Buy) | 115K | Jun 5, 2025 | Direct | ||
Omega Therapeutics, Inc. | Director | Stock Option (Right to Buy) | 50K | Oct 2, 2024 | Direct | ||
Axcella Health Inc. | Director | Stock Option (Right to Buy) | 40K | Nov 16, 2022 | Direct | ||
Evelo Biosciences, Inc. | Director | Stock Option (Right to Buy) | 30K | Jun 8, 2023 | Direct | ||
Seres Therapeutics, Inc. | Director | Stock Option (right to buy) | 10K | Aug 5, 2025 | Direct |
Symbol | Company | Period | Transactions | Value $ | Form Type | Date Filed | Role |
---|---|---|---|---|---|---|---|
MCRB | Seres Therapeutics, Inc. | Aug 5, 2025 | 1 | $0 | 4 | Aug 6, 2025 | Director |
MCRB | Seres Therapeutics, Inc. | Aug 5, 2025 | 0 | $0 | 3 | Aug 6, 2025 | Director |
SANA | Sana Biotechnology, Inc. | Jun 5, 2025 | 1 | $0 | 4 | Jun 9, 2025 | Director |
SANA | Sana Biotechnology, Inc. | Jun 5, 2025 | 0 | $0 | 3 | Jun 9, 2025 | Director |
OMGA | Omega Therapeutics, Inc. | Oct 2, 2024 | 1 | $0 | 4 | Oct 4, 2024 | Director |
OMGA | Omega Therapeutics, Inc. | Oct 2, 2024 | 0 | $0 | 3 | Oct 4, 2024 | Director |
EVLO | Evelo Biosciences, Inc. | Jun 8, 2023 | 1 | $0 | 4 | Jun 12, 2023 | Director |
EVLO | Evelo Biosciences, Inc. | Apr 14, 2023 | 1 | $0 | 4 | Apr 18, 2023 | Director |
EVLO | Evelo Biosciences, Inc. | Apr 14, 2023 | 0 | $0 | 3 | Apr 18, 2023 | Director |
AXLA | Axcella Health Inc. | Nov 16, 2022 | 1 | $0 | 4 | Nov 18, 2022 | Director |
AXLA | Axcella Health Inc. | Oct 10, 2022 | 0 | $0 | 3 | Oct 17, 2022 | Director |